Paoli-Lombardo, R.; Primas, N.; Bourgeade-Delmas, S.; Hutter, S.; Sournia-Saquet, A.; Boudot, C.; Brenot, E.; Castera-Ducros, C.; Corvaisier, S.; Since, M.; Malzert-Fréon, A.; Courtioux, B.; Valentin, A.; Verhaeghe, P.; Azas, N.; Rathelot, P.; Vanelle, P. Improving Aqueous Solubility and In Vitro Pharmacokinetic Properties of the 3-Nitroimidazo[1,2-a]Pyridine Antileishmanial Pharmacophore. Pharmaceuticals 2022, 15 (8), 998. https://doi.org/10.3390/ph15080998.

Smeralda, W.; Since, M.; Corvaisier, S.; Fayolle, D.; Cardin, J.; Duprey, S.; Jourdan, J.-P.; Cullin, C.; Malzert-Freon, A. A Biomimetic Multiparametric Assay to Characterise Anti-Amyloid Drugs. Int. J. Mol. Sci. 2023, 24 (23), 16982. https://doi.org/10.3390/ijms242316982.

Farag, M.; Kieffer, C.; Guedeney, N.; Voisin-Chiret, A. S.; Sopkova-de Oliveira Santos, J. Computational Tool to Design Small Synthetic Inhibitors Selective for XIAP-BIR3 Domain. Molecules 2023, 28 (13), 5155. https://doi.org/10.3390/molecules28135155.

Ţînţaş, M.-L.; Peauger, L.; Barré, A.; Papamicaël, C.; Besson, T.; Santos, J. S. O.; Gembus, V.; Levacher, V. Design, Synthesis and Preliminary Biological Evaluation of Rivastigmine-INDY Hybrids as Multitarget Ligands against Alzheimer’s Disease by Targeting Butyrylcholinesterase and DYRK1A/CLK1 Kinases. RSC Med. Chem. 2024. https://doi.org/10.1039/D3MD00708A.

Vigier, C.; Fayolle, D.; El Siblani, H.; Sopkova – de Oliveira Santos, J.; Fabis, F.; Cailly, T.; Dubost, E. Synthesis and Physicochemical Properties of Cryptophazane—A Soluble and Functionalizable C1-Symmetrical Cryptophane. Angew. Chem. Int. Ed. 2022, 61 (46), e202208580. https://doi.org/10.1002/anie.202208580.

Zhou, Z.; Staropoli, I.; Brelot, A.; Suzanne, P.; Lesnard, A.; Fontaine, F.; Perato, S.; Rault, S.; Helynck, O.; Arenzana-Seisdedos, F.; Sopkova-de Oliveira Santos, J.; Lagane, B.; Munier-Lehmann, H.; Colin, P. Discovery of Bis-Imidazoline Derivatives as New CXCR4 Ligands. Molecules 2023, 28 (3), 1156. https://doi.org/10.3390/molecules28031156.